Nuclear inclusion bodies of mutant and wild‐type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation

Abstract

Although p53 protein aggregates have been observed in cancer cell lines and tumour tissue, their impact in cancer remains largely unknown. Here, we extensively screened for p53 aggregation phenotypes in tumour biopsies, and identified nuclear inclusion bodies (nIBs) of transcriptionally inactive mutant or wild-type p53 as the most frequent aggregation-like phenotype across six different cancer types. p53-positive nIBs co-stained with nuclear aggregation markers, and shared molecular hallmarks of nIBs commonly found in neurodegenerative disorders. In cell culture, tumour-associated stress was a strong inducer of p53 aggregation and nIB formation. This was most prominent for mutant p53, but could also be observed in wild-type p53 cell lines, for which nIB formation correlated with the loss of p53's transcriptional activity. Importantly, protein aggregation also fuelled the dysregulation of the proteostasis network in the tumour cell by inducing a hyperactivated, oncogenic heat-shock response, to which tumours are commonly addicted, and by overloading the proteasomal degradation system, an observation that was most pronounced for structurally destabilized mutant p53. Patients showing tumours with p53-positive nIBs suffered from a poor clinical outcome, similar to those with loss of p53 expression, and tumour biopsies showed a differential proteostatic expression profile associated with p53-positive nIBs. p53-positive nIBs therefore highlight a malignant state of the tumour that results from the interplay between (1) the functional inactivation of p53 through mutation and/or aggregation, and (2) microenvironmental stress, a combination that catalyses proteostatic dysregulation. This study highlights several unexpected clinical, biological and therapeutically unexplored parallels between cancer and neurodegeneration. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

In Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment

“…HEK293 cells (female) stably expressing UbG76V-GFP (Dantuma et al, 2000; De Smet et al, 2017) were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Biochrom) supplemented with 10 % (v/v) fetal bovine serum (Gibco), 2 mM L-glutamine (Gibco), penicillin-streptomycin (Thermo Fisher) and non-essential amino acids (Gibco). Transfection was carried out using FuGENE 6 (Promega).…”

Cell‐to‐cell transmission of C9orf72 poly‐(Gly‐Ala) triggers key features of ALS / FTD

“…HEK293 cells stably expressing Ub G76V ‐GFP (Dantuma et al , ; De Smet et al , ) were transfected with the indicated constructs for co‐culture assays or incubated with conditioned media from GA 175 ‐RFP‐ or RFP‐expressing cells for 48 h. Subsequently, receiver cells were harvested and analyzed by flow cytometry for GFP and RFP fluorescence using an Attune NxT Cytometric Analyser (Thermo Fisher) at the Imaging Facility of the Max Planck Institute of Biochemistry, Martinsried. Fluorescence was detected using the following settings: GFP Ex 488 nm, Em 530/30 nm, tagRFP Ex 561 nm, and Em 586/15 nm.…”

The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer

“…Given that mutant p53 is inhibiting the function of TAp63 and TAp73, it has been postulated that through aggregation, mutant p53 might inactivate its family members, preventing them from interacting with their target gene promoters [51,66]. Aggregation was identified as punctate staining for p53 in the cytoplasm or nucleus [67]. A punctate p53 staining has been identified in cancers with mutant or wildtype p53 expression and has been correlated to worse outcomes [67].…”